Head and neck cancer predictive risk estimator to determine control and therapeutic outcomes of radiotherapy (hnc-predictor): development, international multi-institutional validation, and web implementation of clinic-ready model-based risk stratification for head and neck cancer

HIGHLIGHTS

• who: Lisanne V. van Dijk from the Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA have published the research work: Head and neck cancer predictive risk estimator to determine control and therapeutic outcomes of radiotherapy (HNC-PREDICTOR): development, international multi-institutional validation, and web implementation of clinic-ready model-based risk stratification for head and neck cancer, in the Journal: (JOURNAL)
• what: The aim was to establish a large-scale multiinstitutional standard for a more individualised outcome prediction in patients with HNC of overall survival (OS) and oncologic . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.